I skimmed them and looked at the rankings. Most of the criticism was rooted around cost.
Again, focused on COST. Not related to wait times, deaths while waiting for a specialist, or number of uninsured people who receive care free of charge.
I completely agree that there needs to be reform with the FDA in approving new treatments.
Again, focused on COST. Not related to wait times, deaths while waiting for a specialist, or number of uninsured people who receive care free of charge.
I completely agree that there needs to be reform with the FDA in approving new treatments.


Comment